Sunday, October 5, 2025
8:00 AM – 8:30 AM PT Registration & Breakfast
8:30 AM – 10:00 AM PT CE Symposium
Hilton Anaheim
777 West Convention Way
Anaheim, California
Meeting Room: Pacific Ballroom A
PROGRAM FEATURES
- Downloadable video case
- Interactive case-based presentation
- Create-your-own personalized poster
PRESENTING FACULTY
 |
Elaine Hylek, MD, MPH Professor of Medicine and Director Anticoagulation and Thrombosis Service Boston Medical Center Boston, Massachusetts |
 |
Yaariv Khaykin, MD Associate Professor Temerty Faculty of Medicine University of Toronto Chief Medical Information Officer Cardiac Electrophysiologist Southlake Regional Health Centre Toronto, Ontario, Canada |
PROGRAM OVERVIEW
This program aims to provide insight into the relationship between HTN and AFib, including how each contributes to the risk of HFpEF. Participants will learn to evaluate the role of emerging screening tools, including clinically validated pulse pressure waveform (PPW) technology, in the early detection and monitoring of AFib. Evidence-based strategies will be presented in the context of primary care, so that primary care providers will be able to appropriately screen patients with HTN and others at risk for AFib.
TARGET AUDIENCE
This educational activity aims to equip primary care providers (PCPs), advanced practice providers (e.g., NPs and PAs), and obstetrics and gynecology (OB/GYN) providers involved in the screening and management of patients with or at risk of HTN and AFib with the knowledge necessary to utilize emerging screening technologies to promptly and accurately manage patients at risk of or with AFib to improve their cardiovascular outcomes.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Describe the relationship between HTN and AFib, including how each contributes to the risk of HFpEF
- Evaluate the role of emerging screening tools, including clinically validated pulse pressure waveform (PPW) technology, in the early detection and monitoring of AFib
- Implement evidence-based strategies in the primary care setting to appropriately screen patients with HTN and others at risk for AFib
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.50 ANCC contact hours.
AAFP CREDIT
Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use. For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at [email protected]
